X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.businesswire.com/news/home/20201216005889/en/Galt-Pharmaceuticals-Acquires-Oravig%C2%AE-Miconazole-Buccal-Tablets-50mg-from-Fortovia-Therapeutics
https://www.prnewswire.com/news-releases/m8-pharmaceuticals-and-vectans-pharma-signed-an-exclusive-licensing-agreement-of-loramyc-miconazole-lauriad-for-mexico-and-brazil-301006249.html
https://www.tga.gov.au/submissions-and-tga-response-miconazole-and-fluconazole-proposed-additional-advisory-statements-medicines
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67362a-eng.php
https://www.missionpharmacal.com/press-release/mission-pharmacal-expands-partnership-dara-biosciences
http://www.news-medical.net/news/20150421/Two-existing-drugs-may-reverse-damage-caused-by-multiple-sclerosis.aspx?utm_source=twitterfeed&utm_medium=twitter&utm_campaign=DTN+Pharma+News:
http://blogs.scientificamerican.com/talking-back/2015/04/20/could-a-non-prescription-antifungal-become-a-major-advance-for-multiple-sclerosis/
Market Place
Share 
